1. From the Department of Thoracic Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, London, United Kingdom; EST-Biology, AstraZeneca Pharmaceuticals, Alderley Park, Cheshire, United Kingdom; and the Immunopharmacology Research Group, Medical School, University of Tampere, Finland and Department of Respiratory Medicine, Tampere University Hospital, Tampere, Finland.